<DOC>
	<DOCNO>NCT00023166</DOCNO>
	<brief_summary>Studies PEG-paclitaxel terminate</brief_summary>
	<brief_title>Phase I Study PEG-Paclitaxel In Patients With Advanced Solid Tumors &amp; Lymphomas</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>None Study terminate .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2004</verification_date>
	<keyword>Phase I</keyword>
	<keyword>Open label</keyword>
	<keyword>Safety/efficacy</keyword>
	<keyword>Lymphomas</keyword>
	<keyword>Advanced primary and/or metastatic solid tumor</keyword>
	<keyword>Neoplasms</keyword>
	<keyword>Neoplasm metastasis</keyword>
</DOC>